PepJunkie Home of the Peptonauts
More

Peptide Atlas · Vitamin

Riboflavin

In a three-month randomized trial in 55 people with migraine, high-dose riboflavin (400 mg a day) reduced attack frequency and headache days more than placebo, with 59% responders against 15%.

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Summary

In a three-month randomized trial in 55 people with migraine, high-dose riboflavin (400 mg a day) reduced attack frequency and headache days more than placebo, with 59% responders against 15%. · pmid:9484373

Mechanism

Riboflavin activated by ultraviolet-A light cross-links corneal collagen; treated human corneas became markedly stiffer, the basis of corneal cross-linking for keratoconus. · pmid:14522301

Identity

PubChem CID 493570: Riboflavin, C17H20N4O6, 376.4 g/mol. · pubchem:493570

CAS registry number 83-88-5. · pubchem:493570

IUPAC name: 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione. · pubchem:493570


Where the evidence actually sits

Emerging50%
Preclinical only50%

Proportion of the 2 claims about Riboflavin standing at each tier. Community volume is shown on the Consensus tab beside this and is never averaged into it.


Living evidence history

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. (1998) · emergingStress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. (2003) · preclinical19982003

2 resolved citations, oldest to newest, coloured by tier. Retractions and contradictions land here as they are recorded.


Structure

No structure representation on record. PepJunkie draws only what an authoritative record supplies; for a peptide that is the residue sequence, and none has been curated for Riboflavin yet.


Dose evidence, rung by rung

No established safe human dose. Nothing on file establishes one. That is a statement about the evidence PepJunkie holds, not a promise about the molecule.

  1. Approved-label dose · a resolved regulatory document names a labelled dose

    nothing resolved on this rung

  2. Studied human doses · resolved human studies at the established tier

    nothing resolved on this rung

  3. Observational evidence · resolved human data at the emerging tier: thin, or contested
    • Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. · pmid 9484373 · 1998
  4. Community-reported protocols · protocol propositions from distinct members, counted once per human

    nothing resolved on this rung

  5. Preclinical evidence · resolved animal, cell or mechanistic work
    • Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. · pmid 14522301 · 2003

2 resolved citations, 0 unresolved (an unresolved citation lends nothing). Community volume is its own rung and is never averaged into the evidence rungs.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.